ReviewCardiovascular & hematological disorders drug targets2024

Circumventing Cardiovascular Calamities: The Dawn of ANGPTL3 Blockade in Severe Dyslipidemia Management.

Alim Namitokov et al.PubMed ↗Publisher ↗

No numbers read from the abstract.